{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P26651",
      "entity_text" : "TTP",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P00747",
      "entity_text" : "plasminogen",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR In fact, Tersteeg et al found that a single dose (10 U/mL, corresponding to ~ 20% of the loading dose given for pulmonary embolism) of the plasminogen (human, injected at 20 mg/kg) activator streptokinase was sufficient to attenuate symptoms of TTP and correct the thrombocytopenia in an ADAMTS13 deficient mouse model.",
  "reading_complete" : "2020-08-02T13:44:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:43:18Z",
  "trigger" : "attenuate",
  "evidence" : [ "plasminogen (human, injected at 20 mg/kg) activator streptokinase was sufficient to attenuate symptoms of TTP" ],
  "pmc_id" : "6524877",
  "score" : 0
}